BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 33480647)

  • 21. Association of high microvessel α
    Erdreich-Epstein A; Singh AR; Joshi S; Vega FM; Guo P; Xu J; Groshen S; Ye W; Millard M; Campan M; Morales G; Garlich JR; Laird PW; Seeger RC; Shimada H; Durden DL
    Oncotarget; 2017 Aug; 8(32):52193-52210. PubMed ID: 28881723
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dual inhibition of PI3K and mTOR mitigates compensatory AKT activation and improves tamoxifen response in breast cancer.
    Chen X; Zhao M; Hao M; Sun X; Wang J; Mao Y; Zu L; Liu J; Shen Y; Wang J; Shen K
    Mol Cancer Res; 2013 Oct; 11(10):1269-78. PubMed ID: 23814023
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PI3K/Akt inhibitor partly decreases TNF-α-induced activation of fibroblast-like synoviocytes in osteoarthritis.
    Liu S; Cao C; Zhang Y; Liu G; Ren W; Ye Y; Sun T
    J Orthop Surg Res; 2019 Dec; 14(1):425. PubMed ID: 31829201
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of phosphatidylinositol 3-kinase-Akt signaling blocks growth, promotes apoptosis, and enhances sensitivity of small cell lung cancer cells to chemotherapy.
    Krystal GW; Sulanke G; Litz J
    Mol Cancer Ther; 2002 Sep; 1(11):913-22. PubMed ID: 12481412
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Role of the LY294002 - A Non-Selective Inhibitor of Phosphatidylinositol 3-Kinase (PI3K) Pathway- in Cell Survival and Proliferation in Cell Line SCC-25.
    Duarte A; Silveira GG; Soave DF; Costa JPO; Silva AR
    Asian Pac J Cancer Prev; 2019 Nov; 20(11):3377-3383. PubMed ID: 31759362
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dual-Blocking of PI3K and mTOR Improves Chemotherapeutic Effects on SW620 Human Colorectal Cancer Stem Cells by Inducing Differentiation.
    Kim MJ; Koo JE; Han GY; Kim B; Lee YS; Ahn C; Kim CW
    J Korean Med Sci; 2016 Mar; 31(3):360-70. PubMed ID: 26955235
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polymeric nanomedicine for overcoming resistance mechanisms in hedgehog and Myc-amplified medulloblastoma.
    Kumar V; Wang Q; Sethi B; Lin F; Kumar V; Coulter DW; Dong Y; Mahato RI
    Biomaterials; 2021 Nov; 278():121138. PubMed ID: 34634662
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TAE226, a dual inhibitor of focal adhesion kinase and insulin-like growth factor-I receptor, is effective for Ewing sarcoma.
    Moritake H; Saito Y; Sawa D; Sameshima N; Yamada A; Kinoshita M; Kamimura S; Konomoto T; Nunoi H
    Cancer Med; 2019 Dec; 8(18):7809-7821. PubMed ID: 31692287
    [TBL] [Abstract][Full Text] [Related]  

  • 29. EGFR-mediated signaling pathway influences the sensitivity of oral squamous cell carcinoma to JQ1.
    Liu X; Li Q; Huang P; Tong D; Wu H; Zhang F
    J Cell Biochem; 2018 Oct; 119(10):8368-8377. PubMed ID: 30687956
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antitumor efficacy of PKI-587, a highly potent dual PI3K/mTOR kinase inhibitor.
    Mallon R; Feldberg LR; Lucas J; Chaudhary I; Dehnhardt C; Santos ED; Chen Z; dos Santos O; Ayral-Kaloustian S; Venkatesan A; Hollander I
    Clin Cancer Res; 2011 May; 17(10):3193-203. PubMed ID: 21325073
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PI3K/mTOR inhibition potentiates and extends palbociclib activity in anaplastic thyroid cancer.
    Wong K; Di Cristofano F; Ranieri M; De Martino D; Di Cristofano A
    Endocr Relat Cancer; 2019 Apr; 26(4):425-436. PubMed ID: 30699064
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antitumor activity of ZSTK474, a new phosphatidylinositol 3-kinase inhibitor.
    Yaguchi S; Fukui Y; Koshimizu I; Yoshimi H; Matsuno T; Gouda H; Hirono S; Yamazaki K; Yamori T
    J Natl Cancer Inst; 2006 Apr; 98(8):545-56. PubMed ID: 16622124
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cordycepin induces apoptosis in human bladder cancer T24 cells through ROS-dependent inhibition of the PI3K/Akt signaling pathway.
    Kim SO; Cha HJ; Park C; Lee H; Hong SH; Jeong SJ; Park SH; Kim GY; Leem SH; Jin CY; Hwang EJ; Choi YH
    Biosci Trends; 2019; 13(4):324-333. PubMed ID: 31527329
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epidermal Growth Factor Receptor Regulation of Ewing Sarcoma Cell Function.
    Kersting N; Kunzler Souza B; Araujo Vieira I; Pereira Dos Santos R; Brufatto Olguins D; José Gregianin L; Tesainer Brunetto A; Lunardi Brunetto A; Roesler R; Brunetto de Farias C; Schwartsmann G
    Oncology; 2018; 94(6):383-393. PubMed ID: 29539615
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro antitumor effect of sodium butyrate and zoledronic acid combined with traditional chemotherapeutic drugs: a paradigm of synergistic molecular targeting in the treatment of Ewing sarcoma.
    Dos Santos MP; de Farias CB; Roesler R; Brunetto AL; Abujamra AL
    Oncol Rep; 2014 Feb; 31(2):955-68. PubMed ID: 24316794
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design, synthesis, and biological evaluation of 4,5-dihydro-[1,2,4]triazolo[4,3-f]pteridine derivatives as novel dual-PLK1/BRD4 inhibitors.
    Wang NY; Xu Y; Xiao KJ; Zuo WQ; Zhu YX; Hu R; Wang WL; Shi YJ; Yu LT; Liu ZH
    Eur J Med Chem; 2020 Apr; 191():112152. PubMed ID: 32088495
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bromodomain inhibitor jq1 induces cell cycle arrest and apoptosis of glioma stem cells through the VEGF/PI3K/AKT signaling pathway.
    Wen N; Guo B; Zheng H; Xu L; Liang H; Wang Q; Wang D; Chen X; Zhang S; Li Y; Zhang L
    Int J Oncol; 2019 Oct; 55(4):879-895. PubMed ID: 31485609
    [TBL] [Abstract][Full Text] [Related]  

  • 38. WEE1 accumulation and deregulation of S-phase proteins mediate MLN4924 potent inhibitory effect on Ewing sarcoma cells.
    Mackintosh C; García-Domínguez DJ; Ordóñez JL; Ginel-Picardo A; Smith PG; Sacristán MP; de Álava E
    Oncogene; 2013 Mar; 32(11):1441-51. PubMed ID: 22641220
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PTEN activation sensitizes breast cancer to PI3-kinase inhibitor through the β-catenin signaling pathway.
    Ren Y; Zhou X; Qi Y; Li G; Mei M; Yao Z
    Oncol Rep; 2012 Sep; 28(3):943-8. PubMed ID: 22710837
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radiation sensitization of human cancer cells in vivo by inhibiting the activity of PI3K using LY294002.
    Gupta AK; Cerniglia GJ; Mick R; Ahmed MS; Bakanauskas VJ; Muschel RJ; McKenna WG
    Int J Radiat Oncol Biol Phys; 2003 Jul; 56(3):846-53. PubMed ID: 12788194
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.